11C-methionine and 18F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas

Chinese Medical Journal

Volumn 125, Issue 1, 2012, Pages 91-96

  Li, Dong Li ^a   Xu, Yi Kai ^a   Wang, Quan Shi ^a   Wu, Hu Bing ^a   Li, Hong Sheng ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

11C methionine; 18F fluorodeoxyglucose; Computed tomography; Glioma; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METHIONINE C 11; DIAGNOSTIC AGENT; METHIONINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CHILD; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PRESCHOOL CHILD; RADIOACTIVITY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE; METHODOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; SCINTISCANNING;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; FLUORODEOXYGLUCOSE F18; GLIOMA; HUMANS; MALE; METHIONINE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84862950487     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.01.017     Document Type: Article

References (24)

1. 18F] fluorodeoxyglucose in brain tumors: A powerful diagnostic and prognostic tool. Invest Radiol 1987; 22: 360-371.
2. 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 1998; 50: 1316-1322.
3. 11C-methionine. AJNR Am J Neuroradiol 1996; 17: 345-353.
4. 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med 2008; 49: 694-699.
5. Kletter K. PET/CT: More than the sum of two established imaging modalities? Eur J Radiol 2010; 73: 449-451.
6. 11C]methylation on C18 Sep-Pak. J Labelled Cpd Radiopharm 1999; 42: 715-724.
7. Wong TZ, van der Westhuizen GJ, Coleman RE. Positron emission tomography imaging of brain tumors. Neuroimaging Clin N Am 2002; 12: 615-626.
8. 18F-FDG PET. Eur J Nucl Med Mol Imaging 2002; 29: 176-182.
9. Burger PC, Heinz ER, Shibata T, Kleihues P. Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 1988; 68: 698-704.
10. Galldiks N, Ullrich R, Schroeter M, Fink GR, Jacobs AH, Kracht LW. Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme. Eur J Nucl Med Mol Imaging 2010; 37: 84-92.
11. Delbeke D. Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma, and melanoma. J Nucl Med 1999; 40: 591-603.
12. 11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas. Mol Imaging Biol 2008; 10: 1-18.
13. Okita Y, Kinoshita M, Goto T, Kagawa N, Kishima H, Shimosegawa E, et al. (11)C-methionine uptake correlates with tumor cell density rather than with microvessel density in glioma: A stereotactic image-histology comparison.Neuroimage 2010; 49: 2977-2982.
14. 11C-methionine PET in suspected recurrence of glioma: Sensitivity, inter-observer variability and prognostic value. Eur J Nucl Med Mol Imaging 2005; 32: 39-51.
15. 11C methionine for diagnosis of recurrent brain tumor and radiation injury. Acta Radiol 1991; 32: 197-202.
16. Ogawa T, Shishido F, Kanno I, Inugami A, Fujita H, Murakami M, et al. Cerebral glioma: evaluation with methionine PET. Radiology 1993; 186: 45-53.
17. 11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology. Clin Cancer Res 2004; 10: 7163-7170.
18. Pirotte B, Goldman S, Dewitte O, Massager N, Wikler D, Lefranc F, et al. Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures. J Neurosurg 2006; 104: 238-253.
19. Yamaguchi S, Terasaka S, Kobayashi H, Narita T, Hirata K, Shiga S, et al. Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas. No Shinkei Geka 2010; 38: 621-628.
20. Padma MV, Said S, Jacobs M, Hwang DR, Dunigan K, Satter M, et al. Prediction of pathology and survival by FDG PET in gliomas. J Neurooncol 2003; 64: 227-237.
21. 11C-methionine for PET-guided stereotactic brain biopsy of gliomas. J Nucl Med 2004; 45: 1293-1298.
22. 11C-methionine in the determination of malignancy of gliomas. J Neurol Sci 2006; 246: 85-94.
23. 11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence. AJNR Am J Neuroradiol 2006; 27: 1432-1437.
24. 11C-methionine and computed tomography of intracranial tumours compared with histopathologic examination of multiple biopsies. Acta Radiol 1987; 28: 673-681.